Women who received a false positive result on their previous mammogram were less likely to undergo timely subsequent screening than women who obtained a true negative result, a recent study showed.
Mortality rates of melanoma are predicted to fall by 2050, but the number of individuals dying from the disease will increase due to population growth and ageing.
A recent study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands, shows promise with a breath test measuring five chemicals in the detection of possible gastric and oesophageal cancers.
The improvement in overall survival (OS) among individuals given a combination of gemcitabine and capecitabine as adjuvant chemotherapy after surgically resected pancreatic adenocarcinoma highlights a potential new standard of care, according to findings of the phase III, open-label, multicentre ESPAC-4* trial.
Results from a study presented at the European Cancer Congress 2017 (ECCO 2017) in Amsterdam, the Netherlands showed that rapid deterioration of type 2 diabetes after diagnosis may be an early sign of pancreatic cancer.
Immunotherapy is hailed as clinical cancer advance of the year for the second year by the American Society of Clinical Oncology (ASCO).
Anxiety appears to be associated with increased mortality rate in non-small cell lung cancer (NSCLC) patients, according to a recent study.